TY - JOUR
T1 - Tumor grade improves the prognostic ability of American joint committee on cancer stage in patients with penile carcinoma
AU - Thuret, Rodolphe
AU - Sun, Maxine
AU - Abdollah, Firas
AU - Budaus, Lars
AU - Lughezzani, Giovanni
AU - Liberman, Daniel
AU - Morgan, Monica
AU - Johal, Rupinder
AU - Jeldres, Claudio
AU - Latour, Mathieu
AU - Shariat, Shahrokh F.
AU - Iborra, Franois
AU - Guiter, Jacques
AU - Patard, Jean Jacques
AU - Perrotte, Paul
AU - Karakiewicz, Pierre I.
N1 - Funding Information:
Supported by the University of Montreal Health Center Urology Specialists , Fonds de la Recherche en Santé du Quebec , University of Montreal Department of Surgery , University of Montreal Health Center Foundation (PIK) and Association Française d'Urologie (RT).
PY - 2011/2
Y1 - 2011/2
N2 - Purpose Penile cancer is rare. Thus, predicting cancer specific mortality may be difficult. We devised an accurate and yet easily applicable predictive rule that compares favorably with 2 previous models (73.8% and 74.7% accuracy, respectively). Materials and Methods We identified patients treated with primary tumor excision for all stages of penile squamous cell carcinoma between 1998 and 2006. Disease stage definitions using Surveillance, Epidemiology and End Results stage, American Joint Committee on Cancer stage and TNM classification, and tumor grade were used to predict cancer specific mortality. Predictive accuracy estimates were compared using the DeLong method for related AUCs. Results Surveillance, Epidemiology and End Results stage alone (1 predictor variable) was least accurate (74.5%). American Joint Committee on Cancer stage with tumor grade (2 predictor variables) was the most simple and most accurate (80.9%, p <0.001). A benefit similar to that of American Joint Committee on Cancer stage with tumor grade was seen for TNM classification and TG (80.7%, p = 0.8). However, this rule (4 predictor variables) was more complex than American Joint Committee on Cancer stage and tumor grade. Conclusions American Joint Committee on Cancer stage combined with tumor grade is the simplest, most accurate cancer specific mortality prediction rule after primary tumor excision for penile squamous cell carcinoma. This method is also more accurate than 2 previous cancer specific mortality prediction rules.
AB - Purpose Penile cancer is rare. Thus, predicting cancer specific mortality may be difficult. We devised an accurate and yet easily applicable predictive rule that compares favorably with 2 previous models (73.8% and 74.7% accuracy, respectively). Materials and Methods We identified patients treated with primary tumor excision for all stages of penile squamous cell carcinoma between 1998 and 2006. Disease stage definitions using Surveillance, Epidemiology and End Results stage, American Joint Committee on Cancer stage and TNM classification, and tumor grade were used to predict cancer specific mortality. Predictive accuracy estimates were compared using the DeLong method for related AUCs. Results Surveillance, Epidemiology and End Results stage alone (1 predictor variable) was least accurate (74.5%). American Joint Committee on Cancer stage with tumor grade (2 predictor variables) was the most simple and most accurate (80.9%, p <0.001). A benefit similar to that of American Joint Committee on Cancer stage with tumor grade was seen for TNM classification and TG (80.7%, p = 0.8). However, this rule (4 predictor variables) was more complex than American Joint Committee on Cancer stage and tumor grade. Conclusions American Joint Committee on Cancer stage combined with tumor grade is the simplest, most accurate cancer specific mortality prediction rule after primary tumor excision for penile squamous cell carcinoma. This method is also more accurate than 2 previous cancer specific mortality prediction rules.
KW - carcinoma, squamous cell
KW - mortality
KW - neoplasm staging
KW - nomograms
KW - penis
UR - http://www.scopus.com/inward/record.url?scp=78651267788&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=78651267788&partnerID=8YFLogxK
U2 - 10.1016/j.juro.2010.09.111
DO - 10.1016/j.juro.2010.09.111
M3 - Article
C2 - 21167526
AN - SCOPUS:78651267788
SN - 0022-5347
VL - 185
SP - 501
EP - 507
JO - Journal of Urology
JF - Journal of Urology
IS - 2
ER -